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BACKGROUND: Although widely fragmented BMs have been associated with adverse outcome in several cancer types, comparatively
little is known with respect to its effect on the prognosis of pancreatic cancer. The aim of the current study was therefore to
determine the prognostic value of tumour basement membrane (BM) continuity in two anatomically closely related, however,
prognostically different tumours, pancreatic head- and periampullary cancer.
METHODS: Tumour BM continuity was determined by immunohistochemical staining of its two major components, laminin and
collagen type IV. Associations were made with recurrence free survival (RFS), cancer-specific survival (CSS), overall survival (OS) and
conventional prognostic factors.
RESULTS: Fifty-nine and 61% of pancreatic head and periampullary tumours, respectively, showed limited BM laminin expression.
Whereas 43% and 41% of pancreatic head and periampullary cancers, respectively, showed limited BM collagen type IV expression.
Limited BM laminin was associated with poor outcome following curative resection of pancreatic head cancer (P¼ 0.034, 0.013 and
0.017 for RFS, CSS and OS, respectively). Two and a half times as many patients with X25% BM laminin were recurrence free and
alive 5 years following resection compared with those with limited BM laminin. Although staining patterns of both BM components
were weakly correlated with each other, BM collagen type IV expression was not significantly associated with outcome in either
tumour type.
CONCLUSION: Discontinuous BMs, determined by laminin expression, are associated with poor outcome following curative resection
of pancreatic head cancer.
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Pancreatic cancer is one of the most lethal human cancers.
Resection currently offers the only potential for cure. Owing to
locally advanced disease or the presence of distant metastasis, only
20% of patients are amendable for resection and even following
resection, recurrence remains a major problem (Li et al, 2004). In
fact, almost half of the patients develop recurrent disease within
the first year (Boeck et al, 2007).
Cancer progression and the formation of metastasis is a complex
multi-step process coordinated by the dynamic interaction of
tumour cells with their environment. Under normal circumstances
epithelial cells are separated from the surrounding stroma by a
highly crosslinked and insoluble sheet-like structure called the
basement membrane (BM). Its two major components are laminin
and collagen type IV, where laminin is the centre piece of the
network and collagen type IV provides the scaffold. Apart from its
barrier function, BMs provide structural support and regulate cell
behaviour. Basement membranes are dynamic rather than static
structures, being continuously remodelled by glycoprotein rupture
and synthesis. Tumour BMs are significantly less crosslinked and
therefore more susceptible to proteolysis, remodelling and turn-
over than BMs of normal tissue (Liotta et al, 1983; Martinez-
Hernandez and Amenta, 1983; Kalluri, 2003).
Conceivably, BM continuity is the net effect of tumour
matrix interaction and consequently a reflection of tumour
behaviour. Widely fragmented BMs have been associated with
poor outcome in bladder- (Conn et al, 1987; Daher et al, 1987;
Schapers et al, 1990), colorectal- (Forster et al, 1984; Forster et al,
1986; Havenith et al, 1988), lung (ten Velde et al, 1991) and
hepatocellular cancer (Grigioni et al, 1991). An irregular and
discontinuous deposition of type IV collagen and laminin has also
been observed for BMs of pancreatic cancer (Mollenhauer et al,
1987; Lee et al, 1994; Imamura et al, 1995; Shimoyama et al, 1995;
Linder et al, 2001), however, except for the study by Linder et al,
expression patterns were not studied for their association with
outcome.
We therefore decided to study the distribution of BM laminin
and collagen type IV in relation to conventional prognostic factors
and clinical behaviour of two anatomically closely related,
however, prognostically different pancreatic tumours, pancreatic
head and periampullary cancer.
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PATIENTS AND METHODS
Patient population
Retrospectively, 231 patients treated for pancreatic ductal adeno-
carcinoma with curative intend at Erasmus Medical Center
between 1987 and 2008, who had no microscopically residual
tumour (R0), were identified. Tumours were classified by location,
having their origin either in the pancreatic head or periampullary
region, the latter group comprising of tumours originating in the
Ampulla of Vater or the distal common bile duct. Tumour samples
originating before the new 2002 UICC TNM classification were
re-evaluated according to these new criteria.
Representative tumour areas were encircled on original
haematoxylin/eosin slides by a GI pathologist (KB) with special
expertise in pancreatic pathology and staining was performed on
corresponding formalin-fixed, paraffin-embedded tissue.
During the above-mentioned period two randomised control
trials were ongoing in our centre. Between September 1987 and
April 1995, 17 patients were randomised to the treatment arm of
the EORTC 40891 trial, receiving two courses of 5-FU as a
continuous infusion (max 1500mg per day) followed by radio-
therapy (20Gy). From June 2000 up to its closure in March 2007,
32 patients were randomised to the treatment arm of a trial
combining intra-arterial chemotherapy and radiotherapy. Patients
received six cycles of intra-arterial mitoxantrone (10mgm 2),
folinic acid (170mgm 2 per day), 5-FU (600mgm 2 per day) and
cisplatinum (60mgm 2), the first cycle followed by radiotherapy
(54Gy). These trials and the results have been described in detail
elsewhere (Smeenk et al, 2007; Morak et al, 2008).
At the time of the present report, the median follow-up duration
was 19 months (range 0–192 months). Recurrence-free survival
(RFS) was defined as the time from date of surgery to the date of
first proof of disease recurrence (locally, distant or both) or to
death without relapse. Overall survival (OS) was computed as the
number of months from resection to death of any cause as
registered by the social security death index, whereas for cancer-
specific survival (CSS) only the pancreatic cancer-related deaths
were counted. Patients who died in hospital following procedure-
related complications were excluded from analysis with respect to
survival, as their death was considered unrelated to tumour
biology. This was verified by an evaluation of in hospital death in
relation to the tumour variable BM.
Expression of BM components by immunohistochemistry
Immunohistochemistry was performed according to the protocol
used in clinical practice at our institution and was optimised for
laminin and type IV collagen.
Briefly, 4 mM sections were deparaffinised in xylene and
rehydrated through decreasing ethanol series ending in distilled
water. In case of collagen type IV staining, antigen retrieval was
performed by microwave heating (20min preheating followed by
20min of cooking) in Tris-EDTA buffer pH 9.0, whereas for
laminin staining, proteinase K was applied for 10min. Endogenous
peroxidase activity was quenched using 0.3% hydrogen peroxide in
PBS for 20min. Sections were incubated overnight at 4 1C with a
monoclonal mouse antibody to collagen type IV (CIV 22, M0785,
Dako Netherlands BV, Heverlee, Belgium) or laminin (4C7, reacts
with laminin alpha5; M0638, Dako) at dilutions of 40 and 20 ,
respectively, in Dako REAL antibody diluent (S2022, Dako), which
reduces background staining without the need for additional
blocking steps. Following incubation with the secondary antibody
(Dako REAL Envision HRP Rabbit/Mouse) for 30min at room
temperature, immunostaining was developed by immersion in
diaminobenzidine. Slides were washed extensively between each of
the above steps. Nuclei were counterstained with Harris Haema-
toxylin. Next, slides were dehydrated, fixated and finally covered
using Leica multistainer and robotic cover slipper (ST5020 and CV
5030, Leica Microsystems BV, Rijswijk, The Netherlands). Positive
and negative controls were included in each run.
Tissue evaluation
Slides were examined by light microscopy and scored separately by
three observers (JAvdZ; BMD and TLMtH) blinded to both clinical
and pathological data. As previously described by Havenith et al
(1988) and ten Velde et al (1991), the expression of BM
components was quantified using a visual grading system based
on the percentage of epithelial cell lining. The epithelial cell lining
was either o25% (i.e., limited), 25–75% or 475%.
With respect to laminin expression inter-observer agreement
was moderate (the weighted kappa ranged from 0.48 to 0.56),
whereas inter-observer agreement for collagen type IV was less
good (weighted kappa ranged from 0.34 to 0.48). Discrepant scores
were resolved by consensus.
Basement membranes can only properly be identified by
electron microscopy; with their 40–60 nm thickness, they are
beyond the resolving power of the light microscope. Although BM
zone might therefore have been more appropriate to describe the
observed epithelial cell lining by its major components laminin
and collagen type IV (Kefalides et al, 1979); because of the wide use
of the term BM in other studies, this was also used throughout the
current paper.
Statistical analysis
Statistical analysis was performed using SPSS version 18.0 for
Windows (IBM, Amsterdam, The Netherlands).
Differences in distribution of categorical clinico-pathological
parameters between groups were compared with w2 or Fisher’s
exact tests when appropriate.
The distributions of RFS, CSS and OS were estimated using
Kaplan–Meier methodology. For interpretation purposes analyses
were stratified by tumour origin, that is, pancreatic head or
periampullary. Univariate associations were tested using log-rank
test. Cox proportional hazards regression model was used to test
whether outcome measures were independent of other established
prognostic factors (T status, nodal involvement and tumour
differentiation). Besides these established prognostic factors,
numbers were also corrected for adjuvant therapy to prove that
results were independent of this potentially prognostic factor.
By the use of interaction terms it was investigated whether the
prognostic effect of BM Laminin and collagen IV expression
differed between pancreatic head and periampullary cancers.
All P-values reported are two sided and values p0.05 were
considered statistically significant.
RESULTS
Patient population
Of 231 tumours, 209 were adequately stained for analysis of BM
laminin expression and 214 for analysis of BM collagen type IV
expression. Both patient cohorts consisted of slightly more males
than females, 119 vs 90 and 123 vs 91 in the laminin and collagen
type IV cohorts, respectively. The median age of the patients in
both cohorts was 65 years (range 36–87). Of 47% of tumours the
origin was the pancreatic head, the other 53% were periampullary
cancers. In both cohorts and for both tumour origins fewer
patients had T1/2 tumours than T3/4 tumours, this was more
pronounced in pancreatic head cancers (15% and 36% T1/2
tumours for pancreatic head and periampullary cancers, respec-
tively). The amount of patients with lymph node involvement was
approximately the same as those without lymph node involvement
in both cohorts and for both tumour origins. Furthermore, in both
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patient cohorts and for both tumour types, the majority of
tumours were moderately differentiated, with an equal amount of
well and poorly differentiated tumours (on average 16%). Ten
patients died during their postoperative stay and were thus
excluded from survival analyses.
Basement membrane laminin and collagen type IV
expression
Fifty-nine per cent of pancreatic head cancers showed o25% BM
laminin, thirty per cent 25–75% and eleven per cent 475% BM
laminin expression.
Sixty-one per cent of periampullary tumours showedo25% BM
laminin, thirty-three per cent 25–75% and six per cent 475% BM
laminin expression. An example of BM laminin staining is given in
Figure 1. Interestingly, positive intracellular staining of tumour
cells was also observed.
In contrast, forty-three per cent of pancreatic head cancers
showedo25% BM collagen type IV, forty-six per cent 25–75% and
eleven per cent 475% BM collagen type IV expression. For
periampullary cancer, expression rates were 41.4%, 47.4% and
11.2% for limited, 25–75% and 475% BM collagen type IV
expression, respectively. Figure 2 is an example of BM collagen
type IV staining. Apart from the BM, positive tumour stroma
expression was also observed.
Furthermore, the graded levels of BM laminin and collagen type
IV expression correlated weakly with each other (Spearman
r¼ 0.43 and 0.33 for pancreatic head and periampullary cancers,
respectively, Po0.001). In tumours with more discontinuous BM
laminin staining, generally less BM collagen type IV staining was
observed.
Pathologic correlations
Basement membrane laminin expression was not associated with
any of the conventional prognostic factors (T or N status or grade
of differentiation) in either tumour (i.e., pancreatic head or
periampullary cancer). In contrast BM collagen type IV expression
was associated with grade of differentiation in pancreatic head
cancers (P¼ 0.037). A more fragmented BM collagen type IV
expression pattern was observed in less differentiated tumours.
Clinical correlations
The pancreatic tumour types described, pancreatic head and
periampullar cancer, showed significant different survival beha-
viour. Approximately two times as many patients were recurrence
free and alive 5 years following complete resection of periampul-
lary cancer as compared with pancreatic head cancer (29% vs 16%;
Po0.001 for all outcome measures).
To test whether tumour epithelial BM continuity, as determined
by expression of its two major components laminin and collagen
type IV, affects prognosis of tumours differently, depending on the
tumour origin as specified above, we tested for effect modification
(interaction) by tumour origin in the Cox models. This interaction
test showed that the prognostic effect of BM laminin did not
significantly differ between pancreatic head- and periampullary
cancer. This was true for all outcome measures (P¼ 0.42, 0.19 and
0.35 for RFS, CSS and OS, respectively). Statistically, it would have
been justified to take both tumours (i.e., pancreatic head and
periampullary cancer) together for survival analysis. However,
because of the significantly different survival of pancreatic head
and periampullary cancer, both tumours were analysed separately
for interpretation purposes.
A B
Figure 1 Pancreatic cancer staining with anti-laminin showing both basement membrane and tumour cell staining. (A) 10 magnification. (B) 20
magnification.
A B
Figure 2 Pancreatic cancer staining with anti-collagen type IV showing both basement membrane staining and staining of tumour stroma. (A) 10
magnification. (B) 20 magnification.
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Because of the relatively small amount of tumours classified as
having 475% BM laminin (9 out of 92 and 7 out of 107 of,
respectively, pancreatic head and periampullary cancer), both
categories (25–75% and 475% BM laminin) were taken together
as X25%. Survival analysis showed that BM laminin expression
was significantly associated with outcome following curative
resection of pancreatic head cancer (P¼ 0.034, 0.013 and 0.017
for RFS, CSS and OS, respectively). Ten per cent of patients treated
for pancreatic head cancer showing o25% (i.e., limited) epithelial
BM laminin were recurrence free and alive 5 years following
curative resection of the tumour, whereas more than twice as many
patients (26%) were recurrence free and alive if their tumours
showed X25% BM laminin. A similar trend was observed for
patients treated for periampullary cancer (24% and 39% for
limited and X25% BM, respectively), however, this difference in
survival behaviour was not significant (P¼ 0.16; 0.27 and 0.15 for
RFS, CSS and OS, respectively). (Figure 3) By multivariate analysis
it was shown that limited BM laminin expression is an independent
predictor of poor OS and CSS following curative resection of
pancreatic head cancer. This was not the case for RFS. When
corrected for other prognostic factors such as tumour extent
(T status), nodal involvement, grade of differentiation, BM laminin
expression did however show a trend for an independent
association with RFS (P¼ 0.09) (Table 1). Even when corrected
for the adjuvant treatment given to some patients, BM laminin
expression remained a significant prognostic factor for CSS and
showed a trend for a significant association with RFS and OS
(P¼ 0.11 and 0.058, respectively).
In contrast to BM laminin, BM collagen type IV expression was not
associated with outcome in either type of pancreatic cancer (P¼ 0.35,
0.19 and 0.35; and 0.94, 0.89 and 0.85 for RFS, CSS and OS of pancreatic
head- and periampullary cancer, respectively) (data not shown).
DISCUSSION
This is the largest study to date studying the expression of BM
components in pancreatic cancer specimens and investigating its
potential relation with prognosis following curative resection.
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Figure 3 Recurrence-free survival (RFS) of patients treated for, respectively, pancreatic head (A) and periampullary cancer (B) shows shorter RFS in
patients with tumours with limited basement membrane (BM) laminin expression compared to those with tumours with more continuous BM laminin
expression. This different survival behaviour, however, was only significant for pancreatic head cancers (P¼ 0.034 and 0.16 for pancreatic head and
periampullary cancer, respectively).
Table 1 5-Year survival and multivariate analysis of conventional prognostic factors and tumour BM laminin expression on outcome following curative
resection of pancreatic head cancer
RFS CSS OS
Factor N % 5 Year HR 95% CI P-value % 5 Year HR 95% CI P-value % 5 Year HR 95% CI P-value
Tumour extension 0.30 0.18 0.39
T1/2a 14 29 31 29
T3/4 76 13 1.41 0.74–2.69 17 1.67 0.78–3.56 14 1.33 0.69–2.55
Nodal involvement 0.024 0.006 0.006
Noa 43 30 35 32
Yes 49 3 1.75 1.08–2.86 3 2.10 1.24–3.54 2 1.98 1.22–3.22
Differentiation 0.09 0.08 0.10
Wella 15 33 38 33
Moderately 60 12 1.99 1.04–3.80 0.037 15 1.84 0.89–3.83 0.10 13 1.97 1.03–3.76 0.040
Poorly 16 13 2.12 0.98–4.59 0.056 13 2.69 1.14–6.36 0.024 13 2.02 0.93–4.41 0.08
BM Laminin expression 0.09 0.043 0.050
Limiteda 55 10 11 10
X25% 37 26 0.67 0.42–1.07 31 0.59 0.35–0.98 27 0.63 0.39–1.00
Abbreviations: BM¼ basement membrane; 95% CI¼ 95% confidence interval; CSS¼ cancer-specific survival; HR¼ hazard ratio; OS¼ overall survival; RFS¼ recurrence-free
survival; % 5 year¼% 5 year survival by univariate analysis. aReference category.
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In the current study, approximately one-tenth of pancreatic
head and periampullary tumours showedX75% tumour epithelial
cell lining by BM major components laminin or collagen type IV.
This could be either due to increased turnover by proteolytic
enzymes or decreased synthesis. In the 1980s, Liotta et al already
showed that the rate of spontaneous metastases correlated with
collagen type IV degradation activity in cells. Since then several
matrix metalloproteinase0s have been identified. In the current
study some tumour cells showed immunoreactivity for laminin,
whereas immunostaining for collagen type IV was also observed of
tumour stroma. Accumulation of collagen type IV in the
interstitium was also described by Kalluri (2003) in association
with fibrosis.
In line with the concept that synthesis and modulation of BM
components have a major role in morphogenesis (Martinez-
Hernandez and Amenta, 1983), BM collagen type IV expression
was associated with tumour differentiation of pancreatic head
cancers in our patient cohort. The more patchy BM collagen type
IV staining, the least differentiated the tumour. In contrast,
tumour differentiation was not associated with BM laminin
expression. Both poorly differentiated tumours and well-differ-
entiated tumours showed limited BM laminin expression, the same
was true for tumour extent, an observation that suggests that
disruption of BM laminin is an early process in tumour
progression. The correlation of BM continuity with differentiation
is in line with observations in bladder-, colorectal-, hepatocellular-,
breast-, endometrial cancer and an earlier report on pancreatic
cancer (Albrechtsen et al, 1981; Forster et al, 1984, 1986; Stenback
et al 1985; Mollenhauer et al, 1987; Schapers et al, 1990; Grigioni
et al, 1991; Lazaris et al, 2003; Souza et al, 2007). BM continuity
has also been associated with stage in some tumours (Havenith
et al, 1988; Schapers et al, 1990) and metastasis in others (Forster
et al, 1984; Forster et al, 1986; Mielcarek-Kuchta et al, 2008).
As could have been expected by its highly crosslinked structure
(Kalluri, 2003), BM laminin expression was associated with BM
collagen type IV expression. Generally, tumours with limited BM
laminin deposits also showed scarce collagen type IV expression.
Although widely fragmented BMs have been observed in
pancreatic cancer before (Lee et al, 1994; Imamura et al, 1995;
Shimoyama et al, 1995), there is only one small study of 16 patients
analysing several extracellular matrix proteins and integrins
stating that staining patterns were comparable irrespective of
patient survival (Linder et al, 2001). The lack of an association
between the BM patterns and outcome observed by Linder and co-
workers could be due to the small patient sample. In contrast, in
our study more than twice as many patients were recurrence free
and alive 5 years following resection if their tumours had X25%
BM laminin expression compared with patients with tumours with
o25% BM laminin. In fact, limited BM laminin expression proved
to be an independent predictor of poor survival following curative
resection of pancreatic head cancer. Although BM laminin and BM
collagen IV expression patterns were weakly correlated with each
other, only BM laminin expression was associated with outcome.
BM continuity by collagen type IV expression was not associated
with outcome. BM by laminin was also associated with outcome in
colorectal- (Forster et al, 1984; Forster et al, 1986; Lazaris et al,
2003), bladder- (Schapers et al, 1990) and hepatocellular cancer
(Grigioni et al, 1991). In contrast to our findings a relation with
BM by collagen IV was also observed in several tumours (Daher
et al, 1987; Havenith et al, 1988; Schapers et al, 1990; Grigioni et al,
1991; ten Velde et al, 1991; Lazaris et al, 2003).
There are two mechanisms, by which laminin is thought to be
involved in the formation of metastases. First, laminin has been
reported to be involved in the formation of hemidesmosomes,
biological structures that enable static cell adhesion. Consequently,
decreased expression could cause disassembly or a reduction in
the number of hemidesmosomes, with failure of cell anchoring.
Second, the cleaved form of laminin has been observed to
stimulate motility of epithelial cell types. Therefore, an increased
expression of MMPs that cleave laminin could stimulate cell
motility (Giannelli and Antonaci, 2000). A process in which
activated pancreatic stellate cells might have an essential role
(Schneiderhan et al, 2007).
The lack of a relation of collagen type IV expression with
outcome in our study could theoretically have been caused by the
fair-to-moderate agreement in scoring between the three obser-
vers. Apparently scoring BM collagen type IV expression is rather
complicated. To draw definite conclusions with respect to the
prognostic value of BM collagen type IV expression, other scoring
systems need to be explored.
In conclusion, the current study is the first study that identifies
an independent relationship between tumour BM laminin expres-
sion and prognosis of pancreatic head cancer. Routine tumour BM
laminin staining could potentially differentiate between different
prognostic subgroups of pancreatic head cancer and consequently
aid in therapeutic decision making.
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